Nestlé to Launch $5 'Vital Pursuit' Frozen Food Line for GLP-1 Drug Users

May 21, 2024, 01:40 PM

Nestlé is launching a new frozen food brand called 'Vital Pursuit,' specifically targeting users of GLP-1 drugs such as Wegovy and Ozempic. The new line includes $5 frozen pizzas, sandwiches, and protein-enriched pastas, designed to cater to the dietary needs of individuals using these weight-loss medications. The products, which are also high-fiber and enriched with iron and calcium, will be available in the United States starting in October. Nestlé aims to capitalize on the growing market of GLP-1 drug users, which is expected to reach $30 billion in the next six years.